All of the following are true of the treatment of myasthenia gravis except:
A. The transcervical approach to surgical thymectomy is less likely to benefit the patient with myasthenia gravis.
B. Corticosteroids result in improvement in 80% of patients.
C. Plasma exchange is associated with improvement in up to 90% of patients.
D. Medical therapy with Mestinon (pyridostigmine) is associated with remission in approximately 10% of patients.
E. Surgical thymectomy, regardless of the approach, is associated with improved remission and response rates as compared with medical therapy.
Answer
Category:
Surgery MCQs
POST COMMENT
0 comments:
Post a Comment